Vivo Bio Tech Ltd — Others, 03-07-2025: AGM/EGM

Vivo Bio Tech Limited has announced a postal ballot and e-voting process to seek shareholder approval for increasing its Authorised Share Capital from Rs. 20 Cr to Rs. 30 Cr, divided into 3 crore equity shares of Rs. 10 each. This change will also amend the Capital Clause of the Memorandum of Association. The company aims to facilitate future capital issuances aligned with its operational scale. Voting will be conducted electronically with results announced after completion. This move reflects steps to support potential growth and capital raising flexibility, which may benefit shareholders in the long term.